Abstract
Biliary pseudolithiasis has been reported in patients who received ceftriaxone therapy. In addition to biliary sludge formation occasional reports of ceftriaxone-induced nephrolithiasis have been published. In general, these adverse effects will develop after seven to ten days of treatment. We report on a seven-year-old boy with ceftriaxone-associated biliary pseudolithiasis and nephrolithiasis four days after initiation of treatment. Patients receiving a high dose of ceftriaxone and developing colicky abdominal pain should be considered for ultrasound and a change in antibiotic therapy if appropriate.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 16 February 1999 / Accepted: 9 June 1999
Rights and permissions
About this article
Cite this article
de Moor, R., Egberts, A. & Schröder, C. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis. Eur J Pediatr 158, 975–977 (1999). https://doi.org/10.1007/s004310051261
Issue Date:
DOI: https://doi.org/10.1007/s004310051261